Section 1288.55 Of Article 3.5. Hospital Infectious Disease Control Program From California Health And Safety Code >> Division 2. >> Chapter 2. >> Article 3.5.
1288.55
. (a) (1) Each health facility, as defined in paragraph (3)
of subdivision (a) of Section 1255.8, shall quarterly report all
cases of health-care-associated MRSA bloodstream infection,
health-care-associated clostridium difficile infection, and
health-care-associated Vancomycin-resistant enterococcal bloodstream
infection, and the number of inpatient days.
(2) Each health facility shall report quarterly to the department
all central line associated bloodstream infections and the total
central line days.
(3) Each health facility shall report quarterly to the department
all health-care-associated surgical site infections of deep or organ
space surgical sites, health-care-associated infections of orthopedic
surgical sites, cardiac surgical sites, and gastrointestinal
surgical sites designated as clean and clean-contaminated, and the
number of surgeries involving deep or organ space, and orthopedic,
cardiac, and gastrointestinal surgeries designated clean and
clean-contaminated.
(b) The department's licensing and certification program shall do
all of the following:
(1) Commencing January 1, 2011, post on the department's Web site
information regarding the incidence rate of health-care-acquired
central line associated bloodstream infections acquired at each
health facility in California, including information on the number of
inpatient days.
(2) Commencing January 1, 2012, post on the department's Web site
information regarding the incidence rate of deep or organ space
surgical site infections, orthopedic, cardiac, and gastrointestinal
surgical procedures designated as clean and clean-contaminated,
acquired at each health facility in California, including information
on the number of inpatient days.
(3) No later than January 1, 2011, post on the department's Web
site information regarding the incidence rate of
health-care-associated MRSA bloodstream infection,
health-care-associated clostridium difficile infection, and
health-care-associated Vancomycin-resistant enterococcal bloodstream
infection, at each health facility in California, including
information on the number of inpatient days.
(c) Any information reported publicly as required under this
section shall meet all of the following requirements:
(1) The department shall follow a risk adjustment process that is
consistent with the federal Centers for Disease Control and
Prevention's National Healthcare Safety Network (NHSN), or its
successor, risk adjustment, and use its definitions, unless the
department adopts, by regulation, a fair and equitable risk
adjustment process that is consistent with the recommendations of the
Healthcare Associated Infection Advisory Committee (HAI-AC),
established pursuant to Section 1288.5, or its successor.
(2) For purposes of reporting, as required in subdivisions (a) and
(b), an infection shall be reported using the NHSN definitions
unless the department accepts the recommendation of the HAI-AC or its
successor.
(3) If the federal Centers for Disease Control and Prevention do
not use a public reporting model for specific health-care-acquired
infections, then the department shall base its public reporting of
incidence rate on the number of inpatient days for infection
reporting, or the number of specified device days for relevant
device-related infections, and the number of specified surgeries
conducted for surgical site infection reporting, unless the
department adopts a public reporting model that is consistent with
recommendations of the HAI-AC or its successor.
(d) Health facilities that report data pursuant to the system
shall report this data to the NHSN and the department, as
appropriate.